Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Abeona Therapeutics Inc. (ABEO) vs Inhibikase Therapeutics, Inc. (IKT)

Abeona Therapeutics Inc. and Inhibikase Therapeutics, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Inhibikase Therapeutics, Inc. are of similar size ($303.8M and $293.0M). Abeona Therapeutics Inc. grew revenue faster over the last twelve months: 427.5% against 110.9%. Inhibikase Therapeutics, Inc. has the higher net margin (0.00% vs −242.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Inhibikase Therapeutics, Inc. leads on 9 and Abeona Therapeutics Inc. on 8.

Valuation

Metric ABEO IKT Biotechnology median
P/E n/m n/m 7.88
P/S 11.89 1,380.49 11.47
P/B 2.41 2.35 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 6.80 770.06 10.73
Earnings yield (21.67%) (20.87%) (28.84%)
Free cash flow yield (26.46%) (11.85%) (23.03%)

Profitability

Metric ABEO IKT Biotechnology median
Gross margin 66.03% 100.00% 65.16%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (51.96%) (57.72%)
Return on assets (29.54%) (48.04%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABEO IKT Biotechnology median
Revenue growth (TTM) 427.47% 110.93% 5.64%
EPS growth (last fiscal year) 165.16% 57.76% —
Revenue growth, 5-year CAGR 14.19% (42.21%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO IKT Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 15.82 4.73
Net debt to EBITDA 2.00 3.44 0.96

Dividend

Metric ABEO IKT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABEO IKT Biotechnology median
Market cap 303.77m 293.03m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack